DRIO

DarioHealth Corp.

Nasdaq· Surgical & Medical Instruments & Apparatus· Inc. DE· CIK 0001533998 Healthcare & Medical Devices

$3.48 +0.08 (+2.35%)

Oct 27 4:00 PM ET · prev $3.40

Market cap

$36.9M

Nano cap

Consensus

Buy

82% Buy or better · 11 analysts

Median target

🔒 Subscribers only

Next earnings

Nov 11

in 15 days · EPS est. −$0.51

1 year

−77.3%

from $15.33 · Oct 28

30 days

−48.1%

from $6.71

52-week range

$3.40–15.33

−77% from high · low Oct 26

Avg volume 20D

54.7K

Oct 21 spike 266.2K

Short interest

🔒 Subscribers only

Insider net

+$100.0K

1 buyer · 0 sellers · 12 mo

New fund stakes

Q2 2026 13F · 0 exits

Filing reports

analyzed by SecBot

SecBot read BEARISH 1 report · latest

Balance 1 bearish · 0 bullish oldest → newest, height = score

Avg score

·High conf. 1/1 ·Next Earnings date, Nov 11, 2026

Strongest BEARISH DarioHealth Corp. filed a 424B5 prospectus supplement for a registered direct offering of 2,451,490 shares…

All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

E Jul 20 Trading halt: Halt Resumed: DRIO — trading resumed after LUDP (Volatilit…
E Jul 20 Trading halt: Trading Halt: DRIO — LUDP (Volatility Trading Pause)
R Jul 22 DarioHealth Corp. filed a 424B5 prospectus supplement for a register…
B Jul 23 1 insider buy $100.0K at $6.93
E Aug 11 Trading halt: Halt Resumed: DRIO — trading resumed after LUDP (Volatilit…
E Aug 11 Trading halt: Trading Halt: DRIO — LUDP (Volatility Trading Pause)
A Aug 19 Alliance Global Partners initiates

Signal stack

Where each data set points today.

InsidersBULLISH

1 insider bought $100.0K at an average $6.93. No open-market sales. Price is 50% below their cost.
InstitutionsBULLISH

Q2 2026: 4 added (0 new), 1 trimmed or exited.
AnalystsBULLISH

9 of 11 rate it Buy or better.
EstimatesRISING

Current-quarter EPS estimate −$0.590 → −$0.510 over 90 days. 1 up, 0 down in 30 days.
TrendDOWNTREND

44% below its 50-day average. New closing low $3.40 on Oct 26.

Who's buying

13F· Q2 2026

new positions

exits

Fund	Move	Shares	Value
BlackRock, Inc.	DOUBLED	37,796	$249.5K
MORGAN STANLEY	DOUBLED	3,000	$19.8K
OSAIC HOLDINGS, INC.	DOUBLED	1,900	$12.5K
ROYAL BANK OF CANADA	ADD	658	$4.0K
UBS Group AG	NEAR_EXIT	139	$917.00
UBS Group AG	DOUBLED	15,901	$127.5K
OSAIC HOLDINGS, INC.	NEAR_EXIT	1	$8.00
VANGUARD GROUP INC	DOUBLED	99,301	$1.1M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

11 analysts

Buy 82% rate it Buy or better

Strong Buy3Buy6Hold2Sell0Strong Sell0

Fresh Price Targets

Analyst price targets updated within the last 24 hours are for subscribers only.

Subscribe for Full Access

Recent actions

Date	Firm	Action	Rating
Oct 27, 2026	🔒 Fresh data, subscribers only INITIATE	INITIATE
Aug 19, 2026	Alliance Global Partners INITIATE	INITIATE	Buy
Aug 12, 2026	TD Cowen MAINTAIN	MAINTAIN	Hold
May 14, 2026	Stifel REITERATE	REITERATE	Buy
May 13, 2026	TD Cowen MAINTAIN	MAINTAIN	Hold

Insider ledger

Form 4

$100.0K

bought · 1 insider

sold · 0 insiders

−49.8%

vs their $6.93 cost

Date	Insider	Type	Value
Sep 24, 2026	Franco-Yehuda Chen Chief Financial Officer	AWARD	95,000 sh
Sep 24, 2026	Raphael Erez Chief Executive Officer	AWARD	297,000 sh
Sep 24, 2026	Shaked Yoav Director	AWARD	54,000 sh
Sep 24, 2026	Matheis Dennis Director	AWARD	44,000 sh
Sep 24, 2026	STERN ADAM K Director	AWARD	28,000 sh
Sep 24, 2026	MCGRATH DENNIS M Director	AWARD	61,000 sh
Sep 24, 2026	Karah Hila Director	AWARD	28,000 sh
Sep 24, 2026	PALUMBO JOHN R Director	AWARD	62,000 sh

Earnings setup

Estimates

Nov 11

reports in 15 days

−$0.51

EPS estimate, this quarter

+14%

estimate change, 90 days

1↑ 0↓

revisions, 30 days

Current-quarter EPS estimate

−$0.590

90d

−$0.625

60d

−$0.625

30d

−$0.625

−$0.510

Now

Period	EPS est.	Range	30D rev.	Revenue
Current Q	-$0.51	-$0.51–-$0.51	+18.4%	$5.2M
Next Q	-$0.41	-$0.44–-$0.38	+12.8%	$5.7M
Current FY	-$2.46	-$2.48–-$2.45	+12.3%	$21.9M
Next FY	-$1.12	-$1.46–-$0.78	-64.7%	$30.4M